Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV

Journal of Health Psychology

Volumn 21, Issue 7, 2016, Pages 1311-1321

  Dale, Sannisha K ^a,b,c   Bogart, Laura M ^b,c   Wagner, Glenn J ^d   Galvan, Frank H ^e   Klein, David J ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d RAND CORPORATION   (United States)

^e Bienestar Human Services   (United States)

Author keywords

African American males; beliefs; HIV; medical mistrust; medication adherence

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; CALIFORNIA; ETHNOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; RACISM; STATISTICS AND NUMERICAL DATA; TRUST; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; LOS ANGELES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RACISM; TRUST; YOUNG ADULT;

EID: 84977123197     PISSN: 13591053     EISSN: 14617277     Source Type: Journal    
DOI: 10.1177/1359105314551950     Document Type: Article

References (38)

1. Armstrong K, McMurphy S, Dean LT, et al. (2008) Differences in the patterns of health care system distrust between blacks and whites. Journal of General Internal Medicine 23: 827-833.
2. Armstrong K, Ravenell KL, McMurphy S, et al. (2007) Racial/ethnic differences in physician distrust in the United States. American Journal of Public Health 97: 1283-1289.
3. Arnsten JH, Demas PA, Grant RW, et al. (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine 17: 377-381.
4. Bangsberg D, Hecht F, Charlebois E, et al. (2001) Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior 5: 275-281.
5. Bangsberg DR, (2006) Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases 43: 939-941.
6. Bogart LM, Landrine H, Galvan FH, et al. (2013) Perceived discrimination and physical health among HIV-positive Black and Latino men who have sex with men. AIDS and Behavior 17: 1431-1441.
7. Bogart LM, Wagner G, Galvan FH, et al. (2010a) Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. Journal of Acquired Immune Deficiency Syndromes 53: 648-655.
8. Bogart LM, Wagner GJ, Galvan FH, et al. (2010b) Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Annals of Behavioral Medicine 40: 184-190.
9. Burnett M, Genao I, Wong WF, (2005) Race, culture, and trust: Why should I take a shot if I'm not sick? Ethnicity & Disease 15: S3-13-S3-16.
10. Centers for Disease Control and Prevention (2013) HIV surveillance-Epidemiology of HIV infection (through 2011). Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/slides/general/index.htm
11. Davis JL, Bynum SA, Katz RV, et al. (2012) Sociodemographic differences in fears and mistrust contributing to unwillingness to participate in cancer screenings. Journal of Health Care for the Poor and Underserved 23: 67-76.
12. Gamble VN, (1997) Under the shadow of Tuskegee: African Americans and health care. American Journal of Public Health 87: 1773-1778.
13. Gaston GB, (2013) African-Americans' perceptions of health care provider cultural competence that promote HIV medical self-care and antiretroviral medication adherence. AIDS Care 25: 1159-1165.
14. Gaston GB, Alleyne-Green B, (2013) The impact of African Americans' beliefs about HIV medical care on treatment adherence: a systematic review and recommendations for interventions. AIDS and Behavior 17: 31-40.
15. Golin CE, Liu H, Hays RD, et al. (2002) A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine 17: 756-765.
16. Gulick RM, (2006) Adherence to antiretroviral therapy: How much is enough? Clinical Infectious Diseases 43: 942-944.
17. Hammond WP, Matthews D, Corbie-Smith G, (2010a) Psychosocial factors associated with routine health examination scheduling and receipt among African American men. Journal of the National Medical Association 102: 276-289.
18. Hammond WP, Matthews D, Mohottige D, et al. (2010b) Masculinity, medical mistrust, and preventive health services delays among community-dwelling African-American men. Journal of General Internal Medicine 25: 1300-1308.
19. Hausmann LR, Kressin NR, Hanusa BH, et al. (2010) Perceived racial discrimination in health care and its association with patients' healthcare experiences: Does the measure matter? Ethnicity & Disease 20: 40-47.
20. Hausmann LR, Kwoh CK, Hannon MJ, et al. (2013) Perceived racial discrimination in health care and race differences in physician trust. Race and Social Problems 5: 113-120.
21. Kagee A, Swartz A, Swartz L, (2014) Theorising beyond the individual: Adherence to antiretroviral therapy in resource-constrained societies. Journal of Health Psychology 19: 103-109.
22. Kalichman SC, Pope H, White D, et al. (2008) Association between health literacy and HIV treatment adherence: Further evidence from objectively measured medication adherence. Journal of the International Association of Physicians in AIDS Care (Chic) 7: 317-323.
23. Kobin AB, Sheth NU, (2011) Levels of adherence required for virologic suppression among newer antiretroviral medications. Annals of Pharmacotherapy 45: 372-379.
24. LaVeist TA, Nickerson KJ, Bowie JV, (2000) Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Medical Care Research and Review 57 (Suppl. 1): 146-161.
25. Linn AJ, van Weert JC, van Dijk L, et al. (2014) The value of nurses' tailored communication when discussing medicines: Exploring the relationship between satisfaction, beliefs and adherence. Journal of Health Psychology. Epub ahead of print 4. DOI: 10.1177/1359105314539529.
26. McNabb J, Ross JW, Abriola K, et al. (2001) Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clinical Infectious Diseases 33: 700-705.
27. Madore S, Kilbourn K, Valverde P, et al. (2014) Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients. Support Care in Cancer 22: 2085-2093.
28. Mugavero MJ, Lin HY, Allison JJ, et al. (2009) Racial disparities in HIV virologic failure: Do missed visits matter? Journal of Acquired Immune Deficiency Syndromes 50: 100-108.
29. Muller AD, Myer L, Jaspan H, (2009) Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy. Clinical Infectious Diseases 48: e3-e5.
30. Neacsiu AD, Eberle JW, Kramer R, et al. (2014) Dialectical behavior therapy skills for transdiagnostic emotion dysregulation: A pilot randomized controlled trial. Behaviour Research and Therapy 59C: 40-51.
31. Olem D, Sharp KM, Taylor JM, et al. (2014) Overcoming barriers to HIV treatment adherence: A brief cognitive behavioral intervention for HIV-positive adults on antiretroviral treatment. Cognitive and Behavioral Practice 21: 206-223.
32. Safren SA, O'Cleirigh CM, Bullis JR, et al. (2012) Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology 80: 404-415.
33. Sheppard VB, Mays D, LaVeist T, et al. (2013) Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing. Journal of the National Medical Association 105: 17-22.
34. Shuter J, Sarlo JA, Kanmaz TJ, et al. (2007) HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. Journal of Acquired Immune Deficiency Syndromes 45: 4-8.
35. Silverberg MJ, Leyden W, Quesenberry CP Jr, et al. (2009) Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. Journal of General Internal Medicine 24: 1065-1072.
36. Simoni JM, Huh D, Wilson IB, et al. (2012) Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndromes 60: 466-472.
37. Thrasher AD, Earp JA, Golin CE, et al. (2008) Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 49: 84-93.
38. Tuller DM, Bangsberg DR, Senkungu J, et al. (2010) Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: A qualitative study. AIDS and Behavior 14: 778-784.